Patients News | pharmaphorum

News

Trump's affordability plan arrives, built around MFN pricing

Trump has finally delivered his healthcare proposals, but it seems the 'concept of a plan' promised for many years remains pretty much just that.

News

A globe atlas from above on a white surface

Novartis issues a life sciences warning in a 'G-Zero' world

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

News

FDA seeks changes to GLP-1, flu shot labels

The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.

News

JPM: Anthropic reveals its answer to ChatGPT for Health

Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.

News

Sentynl gets first FDA approval for rare disease Menkes

Children with a devastating, rare disorder of copper metabolism, called Menkes disease, now have an FDA-approved treatment for the first time.

News

JPM: Is the UK's clinical trials sector turning a corner?

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.

Trump's affordability plan arrives, built around MFN pricing

Novartis issues a life sciences warning in a 'G-Zero' world

FDA seeks changes to GLP-1, flu shot labels

JPM: Anthropic reveals its answer to ChatGPT for Health

Sentynl gets first FDA approval for rare disease Menkes

JPM: Is the UK's clinical trials sector turning a corner?

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks